Table 3.
Overall adverse effects of combination therapy using gemcitabine and candesartan in normotensive patients with advanced pancreatic cancer (n = 14)
| All grades, n (%) | Grade 3–4, n (%) | |
|---|---|---|
| Hematological | ||
| Leukopenia | 10 (71) | 3 (21) |
| Neutropenia | 8 (57) | 7 (50) |
| Anemia | 13 (93) | 0 (0) |
| Thrombocytopenia | 11 (79) | 0 (0) |
| Non‐hematological | ||
| Fatigue | 4 (29) | 0 (0) |
| Anorexia | 2 (14) | 0 (0) |
| Nausea | 2 (14) | 0 (0) |
| Constipation | 8 (57) | 0 (0) |
| Diarrhea | 3 (21) | 0 (0) |
| Rash | 2 (14) | 0 (0) |
| Stomatitis | 1 (7) | 0 (0) |
| Hypotension | 5 (36) | 0 (0) |